GPT and metabolic dysfunction-associated steatohepatitis: Six-week administration of rimonabant reversed the increases in hepatic TG deposition, serum levels of ALT and AST, lipid peroxidation, and cell death accompanied by the decreases in gene expression related to proinflammatory cytokines, negative inflammatory mediators, and fibrosis-related protein in a rat model of uncontrolled severe diabetes and early NASH.